Latest Breaking News On - Findings from - Page 4 : comparemela.com

Cytokinetics Announces Four Upcoming Presentations at the

SOUTH SAN FRANCISCO, Calif., March 25, 2024 (GLOBE NEWSWIRE) Cytokinetics, Incorporated (Nasdaq: CYTK) today announced four presentations at the.

Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting

WATERTOWN, Mass., March 13, 2024 Vigil Neuroscience, Inc. , a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases,.

Amylyx Pharmaceuticals to Present Updates on its AMX0114 and RELYVRIO® Programs in ALS at the 2024 Muscular Dystrophy Association (MDA) Clinical and Scientific Conference

Amylyx Pharmaceuticals, Inc. today announced that two abstracts detailing next steps in the development of the Company’s investigational antisense oligonucleotide , AMX0114, for the potential.

New findings from JWST: How black holes switched from creating to quenching stars

Testimony in Opposition to Flavor Bans for Vapor Products and Smokeless Tobacco in Vermont